Innocan Pharma Reports Q2 2023 Results Including US$2.706M Increase in Revenues Compared to Q2, 2022

Posted on by

US$3.121M Revenues for Q2, 2023 compared to US$415,000 for Q2 2022, representing an increase of 652% US$2.656M Gross Profit for Q2, 2023 compared to USD 214,000 for Q2 2022, representing an increase of approximately 1,141% HERZLIYA, Israel and CALGARY, AB, Aug. 25, 2023 /PRNewswire/ –…

Posted in UncategorizedTagged
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.